Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122175232 | 12217523 | 2 | F | 20151031 | 20160725 | 20160329 | 20160804 | EXP | JP-TEVA-646209ISR | TEVA | 74.00 | YR | M | Y | 49.00000 | KG | 20160804 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122175232 | 12217523 | 1 | PS | E-FEN BUCCAL | FENTANYL CITRATE | 1 | Buccal | 0-300 MICROGRAM | Y | 21947 | 100 | UG | TABLET | ||||||
| 122175232 | 12217523 | 2 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.4 MG - 0.8 MG | Y | 0 | |||||||||
| 122175232 | 12217523 | 3 | C | FENTOS | FENTANYL | 1 | Transdermal | 5 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 4 | C | MS-TWICELON | 2 | Oral | 120 MILLIGRAM DAILY; | Y | 0 | ||||||||||
| 122175232 | 12217523 | 5 | C | MS-TWICELON | 2 | Oral | 150 MILLIGRAM DAILY; | Y | 0 | ||||||||||
| 122175232 | 12217523 | 6 | C | OPSO | MORPHINE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | |||||||||
| 122175232 | 12217523 | 7 | C | COCARL | ACETAMINOPHEN | 1 | Oral | 1500 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 8 | C | DECADRON | DEXAMETHASONE | 1 | Oral | 2 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 9 | C | FAMOTIDINE D | FAMOTIDINE | 1 | Oral | 20 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 10 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 1980 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 11 | C | GLIMEPIRIDE OD | 2 | Oral | 1 MILLIGRAM DAILY; | 0 | |||||||||||
| 122175232 | 12217523 | 12 | C | EQUA | VILDAGLIPTIN | 1 | Oral | 100 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 13 | C | PURSENNID | SENNOSIDES A AND B | 1 | Oral | 36 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 14 | C | AMLODIN OD | AMLODIPINE BESYLATE | 1 | Oral | 2.5 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 15 | C | ZOPICLONE | ZOPICLONE | 1 | Oral | 7.5 MILLIGRAM DAILY; | 0 | ||||||||||
| 122175232 | 12217523 | 16 | C | RISPERIDONE. | RISPERIDONE | 1 | Oral | 1 MILLIGRAM DAILY; | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122175232 | 12217523 | 1 | Breakthrough pain |
| 122175232 | 12217523 | 2 | Anxiety |
| 122175232 | 12217523 | 3 | Cancer pain |
| 122175232 | 12217523 | 4 | Cancer pain |
| 122175232 | 12217523 | 6 | Breakthrough pain |
| 122175232 | 12217523 | 7 | Cancer pain |
| 122175232 | 12217523 | 8 | Malaise |
| 122175232 | 12217523 | 9 | Prophylaxis against gastrointestinal ulcer |
| 122175232 | 12217523 | 10 | Constipation prophylaxis |
| 122175232 | 12217523 | 11 | Diabetes mellitus |
| 122175232 | 12217523 | 12 | Diabetes mellitus |
| 122175232 | 12217523 | 13 | Constipation prophylaxis |
| 122175232 | 12217523 | 14 | Hypertension |
| 122175232 | 12217523 | 15 | Insomnia |
| 122175232 | 12217523 | 16 | Insomnia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122175232 | 12217523 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122175232 | 12217523 | Delirium | |
| 122175232 | 12217523 | Tooth loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122175232 | 12217523 | 1 | 20151029 | 20151104 | 0 | |
| 122175232 | 12217523 | 4 | 20151101 | 0 | ||
| 122175232 | 12217523 | 5 | 20151102 | 0 |